论文信息 - A Phase III study of zanubrutinib plus rituximab versus bendamustine plus rituximab in transplant-ineligible, untreated mantle cell lymphoma. - 字舞流文

A Phase III study of zanubrutinib plus rituximab versus bendamustine plus rituximab in transplant-ineligible, untreated mantle cell lymphoma.

W. Novotny | C. Tam | M. Ladetto | M. Dreyling | E. Holmgren | A. Romano | S. Gouill | M. Co | Stephen D. Smith | Michael Wang | Jane E. Huang | Huiqiang Huang